Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2023 16:01 ET | Source: Barinthus Biotherapeutics

Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

OXFORD, United Kingdom, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, today announced its financial results for the third quarter of 2023...
November 09, 2023 08:00 ET | Source: PDS Biotechnology Corporation

PDS Biotech Announces Updated Survival Data from NCI-Led Phase 2 Clinical Trial of PDS0101-Based Triple Combination Therapy in Advanced HPV16-Positive Cancer Patients which Show 75% Survival of ICI Naïve Patients at 36 Months

75% of immune checkpoint inhibitor (ICI) naïve patients remain alive at 36 months; published median overall survival (OS) in similar patients is 7-11 months 12-month survival rate in ICI resistant...
November 09, 2023 02:00 ET | Source: Aspocomp Group Oyj

Aspocompin osavuosikatsaus tammi-syyskuu 2023: Liikevaihto jäi selvästi vertailukaudesta, liiketulos painui tappiolle kolmannella neljänneksellä

Aspocomp Group Oyj, Osavuosikatsaus, 9.11.2023 klo 9.00 KOLMAS NELJÄNNES 2023 LYHYESTI Liikevaihto 8,1 (10,4) miljoonaa euroa, laskua 23 %Liiketulos -0,7 (1,4) miljoonaa euroa, -8,9 (13,1) %...
November 09, 2023 02:00 ET | Source: Aspocomp Group Plc

Aspocomp’s Interim Report January-September 2023: Net sales fell short of the comparison period, operating profit turned negative in the third quarter

Aspocomp Group Plc, Interim Report, November 9, 2023, at 9:00 a.m. (EET) THIRD QUARTER 2023 HIGHLIGHTS Net sales EUR 8.1 (10.4) million, decrease of 23%Operating result EUR -0.7 (1.4) million,...
November 08, 2023 11:42 ET | Source: BPCE

BPCE : Résultats du 3ème trimestre et 9 mois 2023

Paris, le 8 novembre 2023 Résultats du 3ème trimestre et 9 mois 2023 Conquête commerciale, baisse des charges et renforcement de la solvabilité 9M-23 : PNB...
November 08, 2023 11:42 ET | Source: BPCE

Bpce: Results for the 3rd quarter and first 9 months of 2023

Paris, November 8, 2023 Results for the 3rd quarter and first 9 months of 2023 Commercial conquest, costs decrease and solvency reinforcement 9M-23: net banking income of...
November 08, 2023 07:00 ET | Source: Royalty Pharma plc

Royalty Pharma Reports Third Quarter 2023 Results

Net cash provided by operating activities (GAAP) of $574 million and Adjusted Cash Receipts(1) (non-GAAP) of $637 millionAnnounced transactions of up to $3.8 billion year-to-date, including $2.1...
November 08, 2023 01:08 ET | Source: Ambu A/S

ANNUAL REPORT 2022/23 (EARNINGS RELEASE)

For the full 2022/23 financial year, Ambu reported 7.6% organic revenue growth. This was driven by Endoscope Solutions posting 15% organic growth, the main drivers being urology and ENT growing high...
November 02, 2023 08:00 ET | Source: Artidis AG

ARTIDIS Launches Groundbreaking ANGEL Study With Over 2,700 Participants: Transforming Breast Cancer Diagnosis and Personalized Therapy Optimization at the Patient's Bedside

Houston, Texas, and Basel, Switzerland, November 2nd, 2023 – As Breast Cancer Awareness Month concludes, ARTIDIS announces the launch of its global multicenter clinical trial, ARTIDIS Nanomechanical...
November 02, 2023 06:15 ET | Source: Clearway Energy, Inc

Clearway Energy, Inc. Reports Third Quarter 2023 Financial Results

Signed agreement with Clearway Group to commit to invest in the 452 MW Texas Solar Nova solar projectsReceived enhanced offer from Clearway Group to invest in Dan's Mountain WindReceived offer from...